BioAtla
BCAB
41 hedge funds and large institutions have $4.76M invested in BioAtla in 2025 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 12 increasing their positions, 15 reducing their positions, and 28 closing their positions.
0.36% less ownership
Funds ownership: 0.83% → 0.47% (-0.36%)
20% less repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 15
39% less funds holding
Funds holding: 67 → 41 (-26)
66% less capital invested
Capital invested by funds: $14.2M → $4.76M (-$9.44M)
89% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 28
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Acadian Asset Management
Boston,
Massachusetts
|
+$655K |
| 2 |
Squarepoint
New York
|
+$91.3K |
| 3 |
Two Sigma Advisers
New York
|
+$54.5K |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
+$32.6K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$25.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AFM
Anson Funds Management
Dallas,
Texas
|
-$2.72M |
| 2 |
HCM
Highbridge Capital Management
New York
|
-$1.48M |
| 3 |
Millennium Management
New York
|
-$419K |
| 4 |
BCM
Boxer Capital Management
San Diego,
California
|
-$406K |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$383K |
BCAB Hedge Fund Activity: Q1 2025 in Review
41 of the 7,458 institutional investors tracked by Wall St. Rank reported a position in BioAtla (BCAB) for Q1 2025, worth a combined $4.76M — down 66% from $14.2M a quarter earlier.
Sellers outnumbered buyers: 28 funds closed out of BCAB and 3 opened new positions — a net loss of 25 holders — while 15 trimmed existing stakes and 12 added.
The largest buyer was Acadian Asset Management, adding an estimated $655K. The largest seller was Anson Funds Management, exiting entirely with an estimated $2.72M sold.
- 41 institutional investors held BioAtla (BCAB) as of Q1 2025, down from 67 in Q4 2024.
- Funds reported $4.76M of BioAtla stock for Q1 2025, down 66% quarter-over-quarter.
- 3 funds opened new BioAtla positions in Q1 2025 and 28 closed out, a net change of -25 holders.
- The largest BioAtla buyer in Q1 2025 was Acadian Asset Management, an estimated $655K added.
- The largest BioAtla seller in Q1 2025 was Anson Funds Management, an estimated $2.72M sold.
Based on aggregated 13F filings for Q1 2025.